GERON CORP Earnings Per Share (Basic)
GERON CORP (GERN) reported Earnings Per Share (Basic) of -$0.02 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- GERON CORP earnings per share, basic for the quarter ending 2026-06-30 was -$0.02.
- GERON CORP earnings per share, basic for the quarter ending 2026-03-31 was -$0.01.
- GERON CORP earnings per share, basic for the quarter ending 2025-12-31 was -$0.04.
- GERON CORP earnings per share, basic for the quarter ending 2025-09-30 was -$0.03.
- GERON CORP earnings per share, basic for fiscal 2025 was -$0.13.
- GERON CORP earnings per share, basic for fiscal 2024 was -$0.27.
- GERON CORP earnings per share, basic for fiscal 2023 was -$0.32.
- GERON CORP earnings per share, basic for fiscal 2022 was -$0.37.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.02 10-Q · filed 2026-08-05 | -$0.03 10-Q · filed 2026-08-05 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2026-03-31 | -$0.01 10-Q · filed 2026-05-06 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.13 10-K · filed 2026-03-02 |
| 2025-09-30 | -$0.03 10-Q · filed 2025-11-07 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.08 10-Q · filed 2025-11-07 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-06-30 | -$0.02 10-Q · filed 2026-08-05 | -$0.05 10-Q · filed 2026-08-05 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-03-31 | -$0.03 10-Q · filed 2026-05-06 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2024-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.27 10-K · filed 2026-03-02 |
| 2024-09-30 | -$0.04 10-Q · filed 2025-11-07 | -$0.14 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$0.23 10-Q · filed 2025-11-07 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-04-07 |
| 2024-06-30 | -$0.10 10-Q · filed 2025-08-06 | -$0.19 10-Q · filed 2025-08-06 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-04-07 |
| 2024-03-31 | -$0.09 10-Q · filed 2025-05-07 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-04-07 |
| 2023-12-31 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.32 10-K · filed 2026-03-02 |
| 2023-09-30 | -$0.08 10-Q · filed 2024-11-07 | -$0.17 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.23 10-Q · filed 2024-11-07 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-04-07 |
| 2023-06-30 | -$0.09 10-Q · filed 2024-08-08 | -$0.16 10-Q · filed 2024-08-08 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-04-07 |
| 2023-03-31 | -$0.07 10-Q · filed 2024-05-02 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-04-07 |
| 2022-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.37 10-K · filed 2025-02-27 |
| 2022-09-30 | -$0.10 10-Q · filed 2023-11-02 | -$0.17 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$0.26 10-Q · filed 2023-11-02 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-04-07 |
| 2022-06-30 | -$0.07 10-Q · filed 2023-08-03 | -$0.16 10-Q · filed 2023-08-03 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-04-07 |
| 2022-03-31 | -$0.09 10-Q · filed 2023-05-11 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-04-07 |
| 2021-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-04-07 | -$0.35 10-K · filed 2024-02-28 |
| 2021-09-30 | -$0.08 10-Q · filed 2022-11-07 | -$0.17 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$0.26 10-Q · filed 2022-11-07 | |
| 2021-06-30 | -$0.09 10-Q · filed 2022-08-11 | -$0.18 10-Q · filed 2022-08-11 | ||
| 2020-12-31 | -$0.28 10-K · filed 2023-03-16 | |||
| 2017-12-31 | -$0.18 10-K · filed 2018-03-16 | |||
| 2016-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$0.08 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$0.19 10-K · filed 2018-03-16 | |
| 2016-09-30 | -$0.02 10-Q · filed 2016-11-03 | -$0.13 10-Q · filed 2016-11-03 | ||
| 2015-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2018-03-16 | $0.12 derived: net income ÷ weighted average shares · filed 2018-03-16 | $0.00 10-K · filed 2018-03-16 | |
| 2015-09-30 | $0.17 10-Q · filed 2016-11-03 | $0.05 10-Q · filed 2016-11-03 | ||
| 2014-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.12 derived: net income ÷ weighted average shares · filed 2017-03-01 | -$0.23 10-K · filed 2017-03-01 | |
| 2014-09-30 | -$0.06 10-Q · filed 2015-11-05 | -$0.18 10-Q · filed 2015-11-05 | ||
| 2013-12-31 | -$0.30 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |